Cell Based Assays, FDA Approval and Pharmacokinetics

Accelerating Drug Discovery Through Repurposing

DrugBank

FEBRUARY 12, 2025

This approach capitalizes on prior investments in R&D, mitigates risk by leveraging established safety and pharmacokinetic profiles, and accelerates the delivery of treatments to patients. Key techniques include high-throughput screening (HTS), cell-based assays, and animal models.

Cell Based Assays

Cell Based Assays Drugs Pharmacokinetics Disease

ChEMBL 34 is out!

The ChEMBL-og

APRIL 16, 2024

For legacy AUC and Cmax records (< ChEMBL 34), pharmacokinetic parameters have been extracted from the assay descriptions using regular expression matching (RegEx). University of Dundee: T. 1813 bioactivities in total have been added. When possible, AUC record units were converted to ng.hr.mL-1

Clinical Trials

Clinical Trials FDA Cell Based Assays Compound Screening

Drug Discovery Digest

Accelerating Drug Discovery Through Repurposing

ChEMBL 34 is out!

Webinars

Stay Connected